281 related articles for article (PubMed ID: 24328700)
21. Synergistic inhibition of Clostridium difficile with nisin-lysozyme combination treatment.
Chai C; Lee KS; Oh SW
Anaerobe; 2015 Aug; 34():24-6. PubMed ID: 25863312
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial activity of teicoplanin against Clostridium difficile.
Wongwanich S; Kusum M; Phan-Urai R
Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):606-9. PubMed ID: 9185278
[TBL] [Abstract][Full Text] [Related]
23. Effect of alpha-linolenic, capric and lauric acid on the fatty acid biosynthesis in Staphylococcus aureus.
Sado-Kamdem SL; Vannini L; Guerzoni ME
Int J Food Microbiol; 2009 Feb; 129(3):288-94. PubMed ID: 19168249
[TBL] [Abstract][Full Text] [Related]
24. Production of medium chain saturated fatty acids with enhanced antimicrobial activity from crude coconut fat by solid state cultivation of Yarrowia lipolytica.
Parfene G; Horincar V; Tyagi AK; Malik A; Bahrim G
Food Chem; 2013 Feb; 136(3-4):1345-9. PubMed ID: 23194533
[TBL] [Abstract][Full Text] [Related]
25. [Assessment of susceptibility to metronidazole and vancomycin of Clostridium difficile strains isolated between 1998-2002].
Pituch H; Obuch-Woszczatyński P; Glinka D; Łazińska B; Meisel-Mikołajczyk F; Łuczak M
Med Dosw Mikrobiol; 2003; 55(3):253-8. PubMed ID: 14702667
[TBL] [Abstract][Full Text] [Related]
26. Improvement of medium chain fatty acid content and antimicrobial activity of coconut oil via solid-state fermentation using a Malaysian Geotrichum candidum.
Khoramnia A; Ebrahimpour A; Ghanbari R; Ajdari Z; Lai OM
Biomed Res Int; 2013; 2013():954542. PubMed ID: 23971051
[TBL] [Abstract][Full Text] [Related]
27. Comparison of antimicrobial susceptibility among Clostridium difficile isolated from an integrated human and swine population in Texas.
Norman KN; Scott HM; Harvey RB; Norby B; Hume ME
Foodborne Pathog Dis; 2014 Apr; 11(4):257-64. PubMed ID: 24320797
[TBL] [Abstract][Full Text] [Related]
28. Water-in-oil microemulsions containing medium-chain fatty acids/salts: formulation and intestinal absorption enhancement evaluation.
Constantinides PP; Welzel G; Ellens H; Smith PL; Sturgis S; Yiv SH; Owen AB
Pharm Res; 1996 Feb; 13(2):210-5. PubMed ID: 8932438
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial susceptibility patterns of Clostridium difficile strains belonging to different polymerase chain reaction ribotypes isolated in Poland in 2012.
Lachowicz D; Pituch H; Obuch-Woszczatyński P
Anaerobe; 2015 Feb; 31():37-41. PubMed ID: 25242196
[TBL] [Abstract][Full Text] [Related]
30. Nitazoxanide is active against Clostridium difficile strains with reduced susceptibility to metronidazole.
Freeman J; Baines SD; Todhunter SL; Huscroft GS; Wilcox MH
J Antimicrob Chemother; 2011 Jun; 66(6):1407-8. PubMed ID: 21393199
[No Abstract] [Full Text] [Related]
31. In vitro antibiotic susceptibility profile of Clostridium difficile excluding PCR ribotype 027 outbreak strain in Hungary.
Terhes G; Maruyama A; Latkóczy K; Szikra L; Konkoly-Thege M; Princz G; Nagy E; Urbán E
Anaerobe; 2014 Dec; 30():41-4. PubMed ID: 25150212
[TBL] [Abstract][Full Text] [Related]
32. In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole.
Peláez T; Alcalá L; Alonso R; Martín-López A; García-Arias V; Marín M; Bouza E
Antimicrob Agents Chemother; 2005 Mar; 49(3):1157-9. PubMed ID: 15728918
[TBL] [Abstract][Full Text] [Related]
33. Antimicrobial activity of LFF571 and three treatment agents against Clostridium difficile isolates collected for a pan-European survey in 2008: clinical and therapeutic implications.
Debast SB; Bauer MP; Sanders IM; Wilcox MH; Kuijper EJ;
J Antimicrob Chemother; 2013 Jun; 68(6):1305-11. PubMed ID: 23420839
[TBL] [Abstract][Full Text] [Related]
34. Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes.
Freeman J; Vernon J; Morris K; Nicholson S; Todhunter S; Longshaw C; Wilcox MH;
Clin Microbiol Infect; 2015 Mar; 21(3):248.e9-248.e16. PubMed ID: 25701178
[TBL] [Abstract][Full Text] [Related]
35. Effects of natural products on several stages of the spore cycle of Clostridium difficile in vitro.
Roshan N; Riley TV; Hammer KA
J Appl Microbiol; 2018 Sep; 125(3):710-723. PubMed ID: 29675852
[TBL] [Abstract][Full Text] [Related]
36. Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length.
Wanten GJ; Janssen FP; Naber AH
Eur J Clin Invest; 2002 Apr; 32(4):285-9. PubMed ID: 11952815
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility of Clostridium difficile toward antimicrobial agents used as feed additives for food animals.
Aarestrup FM; Tvede M
Microb Drug Resist; 2011 Mar; 17(1):125-7. PubMed ID: 20950192
[TBL] [Abstract][Full Text] [Related]
38. The use of sesame oil and other vegetable oils in the inhibition of human colon cancer growth in vitro.
Salerno JW; Smith DE
Anticancer Res; 1991; 11(1):209-15. PubMed ID: 2018355
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile in broiler chickens sold at market places in Zimbabwe and their antimicrobial susceptibility.
Simango C; Mwakurudza S
Int J Food Microbiol; 2008 Jun; 124(3):268-70. PubMed ID: 18448182
[TBL] [Abstract][Full Text] [Related]
40. Effect of capric, lauric and alpha-linolenic acids on the division time distributions of single cells of Staphylococcus aureus.
Sado Kamdem S; Guerzoni ME; Baranyi J; Pin C
Int J Food Microbiol; 2008 Nov; 128(1):122-8. PubMed ID: 18793815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
